KEVIN M COTTRELL,JOHN J COURT,DAVID D DEININGER,LUC J FARMER,JANOS PITLIK,ROBERT B PERNI
申请号：
HK07106097.2
公开号：
HK1101402B
申请日:
2007.06.07
申请国别(地区):
HK
年份:
2012
代理人:
摘要：
The present invention relates to compounds of formula (I), or a pharmaceutically acceptable salt or mixtures thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection and to processes for preparing the compounds. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention. The invention further relates to processes for preparing theses compounds.
